Did you know last year big Pharma companies Merck, Eli Lilly, Ranbaxy, Pfizer, Johnson & Johnson and Glaxo Smith Kline paid $13 Billion in penalties to different regulatory authorities directly related to counterfeit drugs?
The 7th Pharma Anti-Counterfeiting and Brand Protection Summit will be running again this year, March 26-28 in Philadelphia, PA. This event gathers key decision makers from the sector and provides them with the information and solutions they need to tackle these threats.
Experts estimate that 10% of medicines around the world may be counterfeit. Counterfeiting is growing due to the sophistication of counterfeiting methods and the increases in merchandise crossing borders.